Towards Healthcare
Predictive Disease Analytics Market to Grow at 22.75% CAGR till 2034

Predictive Disease Analytics Market

Projections indicate that, predictive disease analytics industry is projected to rise from USD 3.12 billion in 2024 to USD 24.23 billion by 2034, reflecting a CAGR of 22.75% over the next decade. The predictive analytics majorly contributes to improving patient outcomes, enhancing public health and resource management, and reducing healthcare costs. North America dominated the market in 2024, driven by the widespread adoption of electronic health records, a focus on value-based patient care, and a high prevalence of chronic diseases.

Content

  • Last Updated: 15 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The predictive disease analytics market holds a valuation of USD 3.83 billion as of 2025, and will expand to USD 24.23 billion by 2034, achieving a CAGR of 22.75% between 2024 and 2034.

North America is currently leading the predictive disease analytics market due to the integration of big data, IoT, AI, ML, and cloud-based solutions, support for health IT, and a regulatory framework.

Some key players include Microsoft Healthcare, Google Health, Oracle Health, IBM Watson Health, Optum, etc.

CDC, HHS, AIIMS, WHO, EU, FDA.
Any Questions